View in EDS

Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study.

Saved in:
Bibliographic Details
Title: Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study.
Authors: Brewer, Molly1 (AUTHOR) mbrewer@uchc.edu, Angioli, Roberto2 (AUTHOR), Scambia, Giovani3 (AUTHOR), Lorusso, Domenica3,4 (AUTHOR), Terranova, Corrado2 (AUTHOR), Panici, Pierluigi Benedetti5 (AUTHOR), Raspagliesi, Francesco4 (AUTHOR), Scollo, Paolo6 (AUTHOR), Plotti, Francessco2 (AUTHOR), Ferrandina, Gabriella3 (AUTHOR), Salutari, Vanda3 (AUTHOR), Ricci, Caterina3 (AUTHOR), Braly, Patricia7 (AUTHOR), Holloway, Robert8 (AUTHOR), Method, Michael9 (AUTHOR), Madiyalakan, Madi10 (AUTHOR), Bayever, Eliel10 (AUTHOR), Nicodemus, Christopher11 (AUTHOR)
Source: Gynecologic Oncology. Mar2020, Vol. 156 Issue 3, p523-529. 7p.
Database: Academic Search Ultimate
Description
ISSN:00908258
DOI:10.1016/j.ygyno.2019.12.024